Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2009 | 10-2008 | 10-2007 | 10-2006 | 10-2005 | |
| Sales | 407 | 223 | 201 | 818 | 1,309 |
| Cost of Goods | 328 | 148 | 168 | 773 | 897 |
| Gross Profit | 79 | 75 | 33 | 45 | 413 |
| Operating Expenses | 128 | 107 | 196 | 247 | 321 |
| Operating Income | -49 | -32 | -163 | -202 | 92 |
| Interest Expense | 16 | 15 | N/A | N/A | N/A |
| Other Income | 65 | 47 | 163 | 202 | -92 |
| Net Income Continuous | -69 | -24 | -184 | -352 | 72 |
| Net Income | $-69 | $-24 | $-184 | $-352 | $72 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 |
| EBITDA(a) | $-45 | $-26 | $-155 | $-182 | $127 |